Critical Metals Corp. enters the week in a state of near-total lending lockdown — availability has collapsed to essentially zero while short interest keeps climbing, creating one of the more charged short-side setups in the critical minerals space.
The borrow story has deteriorated further since the June 30 note documented an availability collapse to 6.8%. What was already a tight lending market is now at its absolute limit. Availability has fallen to just 0.08% — fewer than one share remains available for every thousand already lent out. That is the lowest reading since the 52-week floor of 0.0012%. Cost to borrow has risen to 95%, up 19% on the week and more than triple where it was a month ago. Every share in the lending pool is currently lent out, meaning new short positions are effectively locked out of the borrow market unless existing holders sell. The direction has been one-way: availability briefly recovered into the low teens in early July before snapping shut again over the past two sessions.
Short interest itself keeps building despite those conditions. At 20.8% of the free float — up from 19.9% at the last note — nearly one in five freely-traded shares is already sold short. That figure has risen roughly 9% over the past month. The FINRA fortnightly count, which settled at 20.9 million shares as of mid-June, broadly corroborates the daily estimate. Days to cover sits at 3.1. The ORTEX short score has climbed to 83.1, up from 80.7 ten days ago and trending higher every session this week — a reading that places CRML in the most extreme short-pressure cohort across the platform. Options positioning, by contrast, reads as unremarkable. The put/call ratio is 0.57, barely above its 20-day average of 0.55 and well within one standard deviation of normal. Options traders are not adding meaningful directional conviction on top of what the equity lending market is already saying.
The Street picture is thin and dated. The only coverage on file comes from two initiations — Freedom Broker set a Buy with a $15 target in March 2026, and Clear Street initiated at Buy with a $12 target in September 2025. Both are outside the 14-day window for fresh analyst colour. The mean target of $17 sits well above the current $8.75 close, but given how stale that data is, the gap should be treated with caution rather than as a strong valuation signal. The ORTEX factor scores reinforce the caution: the short score rank is in the bottom percentile of the universe (rank 0), the days-to-cover rank is a modest 20, and dividend and sector scores are both near the middle of the range. On valuation, only the enterprise value is available at roughly $862 million — no earnings multiples exist, consistent with a company still in development-stage territory.
The ownership picture adds one structural wrinkle. European Lithium Limited remains the dominant holder at 31% of shares, and reported selling 7.5 million shares as of the February filing. Westrip Holdings, the second-largest at 9.9%, added 2.8 million shares as recently as late April. Those two blocs together represent over 40% of the share count — meaning the effective free float is considerably smaller than the headline figure, which helps explain why the lending market reaches maximum tightness so readily. BlackRock and Morgan Stanley both added shares in Q1, though at combined positions under 4%, their influence on price dynamics is limited.
The stock fell 5.5% on Tuesday and is down 14.6% on the week to $8.75, a sharper move than most sector peers. MP Materials dropped 7.8% on the week, USAR fell 15.5%, and NB lost 2.8% — so CRML's decline is not entirely idiosyncratic, but it is tracking the weaker end of the peer range. The next earnings event is flagged for October 6. Between now and then, the tension to watch is whether the stock's continued slide puts pressure on existing short positions — at 95% cost to borrow and near-zero availability, any meaningful covering could move quickly in a thin lending pool.
See the live data behind this article on ORTEX.
Open CRML on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
